Trial Profile
Continuous use of Oral contraceptives as an alternative for long term Pituitary down-regulation with a GnRH agonist prior to IVF/ICSI in Endometriosis patients: a randomised controlled trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2019
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Leuprorelin; Leuprorelin; Tibolone
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms COPIE trial
- 16 Nov 2019 Planned number of patients changed from 300 to 330.
- 20 Apr 2017 New trial record